# Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT

> **NCT06177561** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **PROCEDURE:** Lymphoplasma exchange

## Key facts

- **NCT ID:** NCT06177561
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-09
- **Primary completion:** 2024-11-08
- **Final completion:** 2025-11-08
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177561, "Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06177561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*